SEMA4C and breast cancer: this study verified the effect of miR-138 targeting SEMA4C on the EMT-related proteins of BC cells to verify that miR-138 targeting SEMA4C acts on the epithelial-mesenchymal transition of BC cells, thereby affecting the viability and metastasis of BC cells.